Barret J M, Montaudon D, Etiévant C, Perrin D, Kruczynski A, Robert J, Hill B T
Division de Cancérologie, Centre de Recherche Pierre Fabre, 17 avenue Jean Moulin 81100 Castres, France.
Anticancer Res. 2000 Nov-Dec;20(6B):4557-62.
F 11782, or 2", 3"-bis pentafluorophenoxyacetyl-4',6'-ethylidene-beta-D glucoside of 4'-phosphate-4'-dimethylepipodophyllotoxin 2N-methyl glucamine salt, is a novel fluorinated lipophylic epipodophylloid which has proven cytotoxic activity in vitro and has shown markedly superior antitumour activity in vivo compared to etoposide in various experimental tumour models. However, the precise mechanism(s) of cytotoxicity of F 11782 remains to be defined. In this study, the DNA damaging activity of F 11782 was investigated in GCT27 and C6S cells using, respectively the fluorescence enhancement assay and the technique of DNA alkaline elution. All the results obtained were consistent with induction of DNA damage by F 11782. No evidence of any stabilisation of DNA-topoisomerase cleavable complexes though was obtained with this catalytic inhibitor. Furthermore, such induction of DNA damage has not been reported with other known catalytic topoisomerase inhibitors and so it appears to be unique to F 11782.
F 11782,即4'-磷酸-4'-二甲基表鬼臼毒素2N-甲基葡糖胺盐的2", 3"-双五氟苯氧基乙酰基-4',6'-亚乙基-β-D-葡糖苷,是一种新型氟化亲脂性鬼臼毒素类化合物,已证实其在体外具有细胞毒性活性,并且在各种实验性肿瘤模型中,与依托泊苷相比,在体内显示出明显更优的抗肿瘤活性。然而,F 11782细胞毒性的确切机制仍有待确定。在本研究中,分别使用荧光增强测定法和DNA碱性洗脱技术,在GCT27和C6S细胞中研究了F 11782的DNA损伤活性。所获得的所有结果均与F 11782诱导DNA损伤一致。不过,使用这种催化抑制剂未获得DNA-拓扑异构酶可切割复合物任何稳定化的证据。此外,其他已知的催化性拓扑异构酶抑制剂并未有这种DNA损伤诱导的报道,因此这似乎是F 11782独有的。